Laboratory Testing - what we need and what we don't?

被引:9
|
作者
Moeckel, Martin [1 ,2 ,3 ]
Mueller, Christian [4 ,5 ]
Lindner, Tobias [6 ,7 ]
Searle, Julia [7 ,8 ]
机构
[1] Campus Virchow Klinikums, Arbeitsbereichs Notfallmed Rettungsstellen Aufnah, Berlin, Germany
[2] Campus Virchow Klinikums, Chest Pain Units, Berlin, Germany
[3] Campus Charite Mitte, Berlin, Germany
[4] Charite, Zent Lab, Berlin, Germany
[5] Charite, Forsch Grp Arbeitsbereiches Notfallmed, Berlin, Germany
[6] Charite, Chirurg & Unfallchirurg Orthopadie Klin Notfall &, Berlin, Germany
[7] Charite, Arbeitsbereiches Notfallmed, Berlin, Germany
[8] Charite, Bereich Forsch, Berlin, Germany
关键词
EMERGENCY-DEPARTMENT; PROCALCITONIN; DIAGNOSIS; GUIDELINES; MANAGEMENT; OUTCOMES; SOCIETY; SEPSIS; IDENTIFICATION; DISORDERS;
D O I
10.1055/s-0041-109207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laboratory parameters in emergency medicine can be divided into 3 categories. Urgent obligatory parameters are necessary for immediate therapeutic decisions and must be available within 60 minutes. For these, testing in the emergency department (ED) as point-of-care-testing (POCT) should be considered. The second category are obligatory parameters which require diagnostic/therapeutic consequences in the emergency department, but are not necessary for immediate life-saving actions. Due to international consensus of a 4-hour length of stay target for ED, results should be available within this time. The third category are parameters which do not lead to immediate diagnostic or therapeutic consequences, but are important for process management and patient flow in the ED. They should therefore be available as emergency tests. POC-testing should be used for a limited number of very urgent parameters and should be organized as a satellite laboratory in cooperation with the central laboratory.
引用
收藏
页码:322 / +
页数:9
相关论文
共 50 条
  • [1] Pleural infection: what we need to know but don't
    Tobin, Claire L.
    Lee, Y. C. Gary
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (04) : 321 - 325
  • [2] Fibroblast growth factor-23: what we know, what we don't know, and what we need to know
    Kovesdy, Csaba P.
    Quarles, Leigh Darryl
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (09) : 2228 - 2236
  • [3] We don't know what we need to know about atrial fibrillation
    McCarthy, Patrick M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04) : 1522 - 1523
  • [4] Destination competitiveness: what we know, what we know but shouldn't and what we don't know but should
    Abreu-Novais, Margarida
    Ruhanen, Lisa
    Arcodia, Charles
    CURRENT ISSUES IN TOURISM, 2016, 19 (06) : 492 - 512
  • [5] Organizational unlearning as a process: What we know, what we don't know, what we should know
    Klammer, Adrian
    Grisold, Thomas
    Nguyen, Nhien
    Hsu, Shih-wei
    MANAGEMENT REVIEW QUARTERLY, 2024,
  • [6] Diversity: What We Know, What We Need to Know, and What We Need to Do
    Dukes, Charles
    Lamar-Dukes, Pamela
    RESEARCH AND PRACTICE FOR PERSONS WITH SEVERE DISABILITIES, 2009, 34 (3-4) : 71 - 75
  • [7] What we don't know about osteoporosis
    Lewiecki, E. M.
    Binkley, N.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (05): : 491 - 493
  • [8] Lipedema: What we don't know
    van la Parra, R. F. D.
    Deconinck, C.
    Pirson, G.
    Servaes, M.
    Fosseprez, Ph.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2023, 84 : 302 - 312
  • [9] What we know and what we don't know about the perioperative use of methadone in children and adolescents
    Boisvert-Plante, Virginie
    Poulin-Harnois, Christelle
    Ingelmo, Pablo
    Einhorn, Lisa M.
    PEDIATRIC ANESTHESIA, 2023, 33 (03) : 185 - 192
  • [10] Primary angle closure glaucoma: What we know and what we don't know
    Sun, Xinghuai
    Dai, Yi
    Chen, Yuhong
    Yu, Dao-Yi
    Cringle, Stephen J.
    Chen, Junyi
    Kong, Xiangmei
    Wang, Xiaolei
    Jiang, Chunhui
    PROGRESS IN RETINAL AND EYE RESEARCH, 2017, 57 : 26 - 45